Science Explorer Interactive view Map

Provid Pharmaceuticals (United States)

Research works
29
▼ 41% vs 2013–17
Citations
512
17.6 per fractional work
Top-10% rate
9.5%
record average 16.5%
Open access
19%
world 28%

Not ranked overall: Provid Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 7.51× its world share, 1 worksBiochemistry, Geneti…Neuroscience: 1.95× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.48× its world share, 0 worksPharmacology, Toxico…Chemistry: 10.08× its world share, 0 worksChemistryComputer Science: 0.81× its world share, 0 worksComputer ScienceMedicine: 1.56× its world share, 1 worksMedicineEconomics, Econometrics and Finance: 0.92× its world share, 0 worksEconomics, Econometr…world share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Chemistry, 10.1×. Every wedge is a field page.

Which keywords describe research at Provid Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Reactive Oxygen Species, Complications, Photodynamic Therapy, Nanoparticles, Chemotherapy, Chronic Pain, Oxidative Stress and TGF-ß.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 21 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Epidemiology2▲ 1.68×8 topics
  2. Nanoparticles2▲ 5.2×6 topics
  3. Oxidative Stress2▲ 3.8×12 topics
  4. Reactive Oxygen Species2▲ 13×4 topics
  5. Complications2▲ 12×3 topics
  6. Photodynamic Therapy2▲ 40×3 topics
  7. Chemotherapy2▲ 7.7×5 topics
  8. Chronic Pain2▲ 23×3 topics
  9. TGF-ß1▲ 28×3 topics
  10. Antibiotic Resistance1▲ 11×5 topics
  11. Cancer Therapy1▲ 7.0×5 topics
  12. Hernia Repair1▲ 167×1 topic
  13. Mesh Techniques1▲ 167×1 topic
  14. Chronic Kidney Disease1▲ 16×2 topics
  15. Graft Survival1▲ 41×2 topics
  16. Apoptosis1▲ 10.0×5 topics
  17. Gene Therapy1▲ 14×3 topics
  18. Immunotherapy1▲ 5.9×2 topics
  19. Tumor Targeting1▲ 29×2 topics
  20. Biosensors1▲ 6.0×2 topics
  21. Gene Expression1▲ 5.6×2 topics

Which research topics does Provid Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Antibiotic Resistance in Bacteria, Synthesis and Biological Evaluation, Antimicrobial Resistance in Staphylococcus and Cancer-related Molecular Pathways.

  1. 1 Antibiotic Resistance in Bacteria Molecular Medicine 0 works
  2. 2 Synthesis and Biological Evaluation Organic Chemistry 0 works
  3. 3 Antimicrobial Resistance in Staphylococcus Infectious Diseases 0 works
  4. 4 Cancer-related Molecular Pathways Oncology 0 works
  5. 5 Advanced Neural Network Applications Computer Vision and Pattern Recognition 0 works
  6. 6 Medical Image Segmentation Techniques Computer Vision and Pattern Recognition 0 works
  7. 7 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
  8. 8 Brain Tumor Detection and Classification Neurology 0 works
  9. 9 Bacterial biofilms and quorum sensing Molecular Biology 0 works
  10. 10 Bacterial Genetics and Biotechnology Genetics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available18.8%not open81.2%

World: 28% of research is openly available.

with international co-authors22.8%domestic only77.2%

World: 19% is written across borders.

How has Provid Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 41% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Monmouth Junction

All research institutions in Monmouth Junction

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.